CLGN - Company ID 0001631487
The table below shows CollPlant Biotechnologies Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.37M | $515.00K | $10.96M | $299.00K | $15.64M | $6.14M |
| Cost of revenue | $835.00K | $1.63M | $1.99M | $400.00K | $2.00M | $3.00M |
| Gross profit | $1.54M | -$1.11M | $8.97M | -$101.00K | $13.64M | $3.13M |
| R&D | $8.19M | $10.52M | $10.48M | $10.26M | $7.63M | $4.07M |
CollPlant Biotechnologies Ltd reported annual revenue of $2.37M for fiscal year 2025. That is up 360.4% from $515.00K in fiscal 2024. Over the 8 fiscal years shown, annual revenue declined from $5.01M (FY 2018) to $2.37M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $4.83M |
| $5.63M |
| $6.00M |
| $6.74M |
| $5.94M |
| $4.67M |
| Operating income | -$11.48M | -$17.25M | -$7.51M | -$17.10M | $65.00K | -$5.60M |
| Income tax | - | $45.99M | $59.99M | - | - | - |
| Net income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237.00K | -$5.77M |
| EPS (diluted) | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | -$0.84 |